Goniotomy for Glaucoma
What You Need to Know Before You Apply
What is the purpose of this trial?
The goal of this study is to determine of one of three different devices to perform goniotomy to treat glaucoma at the time of cataract surgery is more or less effective than the others. The primary outcomes are to compare intraocular pressure control and glaucoma medication use up to 6 months after surgery. Participants will under combined cataract surgery and goniotomy. They will have post-operative follow up visits at 1 day, 1 week, 1 month, 3 months, and 6 month
Who Is on the Research Team?
David A Crandall, MD
Principal Investigator
Henry Ford Health
Are You a Good Fit for This Trial?
Inclusion Criteria
Exclusion Criteria
Timeline for a Trial Participant
Screening
Participants are screened for eligibility to participate in the trial
Treatment
Participants undergo combined cataract surgery and goniotomy using one of three devices
Follow-up
Participants are monitored for intraocular pressure control and glaucoma medication use
What Are the Treatments Tested in This Trial?
Interventions
- Goniotomy
How Is the Trial Designed?
3
Treatment groups
Active Control
Goniotomy performed with SION
Goniotomy performed with bent needle
Goniotomy performed with Tanito hook
Find a Clinic Near You
Who Is Running the Clinical Trial?
Henry Ford Health System
Lead Sponsor
Unbiased Results
We believe in providing patients with all the options.
Your Data Stays Your Data
We only share your information with the clinical trials you're trying to access.
Verified Trials Only
All of our trials are run by licensed doctors, researchers, and healthcare companies.